Procyrion, Inc. Recognized as Top Life Science Company

BioNews Texas

Houston-based Procyrion, Inc. has made it into Texas biotech headlines several times, most recently in late January when the company announced that it had received a second tranche of $1.5 million in funding from the Texas Emerging Technology Fund. Now, in the wake of the successful 2014 Texas Life Science Forum, which was held in late February, it appears that Procyrion has made good use of its financial support, having been recognized by the Rice Alliance as a “Top Life Science Company” for its Aortix™ medical device. BioNews Texas has profiled the Aortix before, which is “the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure,” according to a recent press release. Of the 55 different biotech and pharma companies that participated in this year’s forum, only 10 of them received this distinction.

Read More